Welcome to our dedicated page for Acacia Research Corporation news (Ticker: ACTG), a resource for investors and traders seeking the latest updates and insights on Acacia Research Corporation stock.
Acacia Research Corporation (Nasdaq: ACTG) is a leading company in the field of patent licensing and strategic business acquisitions. By partnering with patent owners, Acacia uses its extensive legal and technological expertise to unlock substantial financial value from patent assets, serving as an intermediary in the patent market to enhance efficiency and deliver monetary rewards to patent owners. Since its inception, Acacia has generated over $1.2 billion in revenue and returned more than $705 million to its patent partners.
Acacia's business model focuses on acquiring and managing companies across diverse industries such as industrial, energy, technology, and healthcare. Through strategic acquisitions, restructurings, and investments, the company aims to unlock value in these businesses. Acacia operates three primary segments: Intellectual Property Operations, Industrial Operations, and Energy Operations. The Intellectual Property segment specializes in licensing and enforcing patented technologies. The Industrial segment designs and manufactures printers and consumable products for industrial printing applications, while the Energy segment is involved in oil and gas exploration, development, and production.
As of November 2023, Acacia announced its financial results for the third quarter of 2023, revealing a consolidated revenue of $10.1 million. This includes a significant achievement with the sale of its shares in Arix Bioscience PLC for $57.1 million, expected to complete in Q1 2024. Acacia also acquired a majority stake in Benchmark Energy II LLC, focusing on the growth of oil and gas assets in Texas and Oklahoma. Additionally, the company approved a stock repurchase program valued at up to $20 million.
Acacia continues to pursue attractive business opportunities based on the attractiveness of underlying cash flows, irrespective of a specific investment horizon. With a robust capital base and deep industry relationships, Acacia is well-positioned to drive value in its acquired businesses by focusing on people, process, and performance.
Acacia Research Corporation (NASDAQ: ACTG) will announce its third quarter 2022 financial results before the market opens on November 10, 2022. The company is hosting a conference call on the same day at 11:00 a.m. ET to discuss the results, which can be accessed by calling 888-506-0062 (U.S.) or 973-528-0011 (international), using conference ID 958547. The call will also be available via webcast on Acacia's investor relations website for 30 days post-event.
Acacia Research Corporation (NASDAQ: ACTG) announced a transformative agreement with Starboard Value LP, which will invest over $245 million and convert all ownership interests to common shares. CEO Clifford Press is retiring, with MJ McNulty appointed as interim CEO. The deal simplifies Acacia's capital structure, eliminating $133.2 million of derivative liabilities and $95 million in debt. A rights offering at $5.25 per share is planned, with Starboard committed to buy at least 15 million shares. Acacia's pro forma book value is set to rise by at least $265.7 million.
Acacia Research Corporation (ACTG) has extended the Cash Exercise Date for its Series B Warrants by four weeks, moving it from September 30, 2022 to October 28, 2022. This extension is part of the ongoing discussions between Acacia and Starboard Value LP aimed at simplifying capital structure and enhancing resources for growth. Acacia's CEO, Clifford Press, emphasized the progress made in establishing a suitable capital structure and the urgency in finalizing these arrangements.
Acacia Research Corporation (ACTG) reported a Q2 2022 revenue of $16.7 million, down from $17.4 million in Q2 2021. The company recorded $11.5 million in realized gains, including $5.2 million from its Life Science Portfolio. Acacia repurchased 6.1 million shares at an average price of $4.64 as part of a $40 million buyback program. Additionally, the company repaid $50 million in debt. However, there was a substantial GAAP net loss of $61.5 million compared to a net income of $19.7 million last year.
Acacia Research Corporation (NASDAQ: ACTG) will release its second quarter 2022 financial results on August 11, 2022, before market opening. A conference call will follow at 11:00 a.m. ET to discuss the results. To participate, dial 888-506-0062 or 973-528-0011 (international) with conference ID 536777. The call will also be available via webcast on the company’s website. Acacia Research focuses on acquiring undervalued businesses to create value through strategic acquisitions, leveraging expertise in corporate governance, operational restructuring, and access to capital.
Acacia Research reported Q1 2022 financial results, achieving $13.5 million in total revenue, a significant increase from $5.8 million in Q1 2021. This included $10.9 million from Printronix, acquired in October 2021. The company recorded $66.9 million in realized gains, primarily from its Life Science Portfolio, and completed a $15 million share repurchase. However, Acacia faced a $73.3 million net loss due to unrealized losses totaling $(172.2 million). The current book value decreased to $7.42 per share.
Acacia Research Corporation (NASDAQ: ACTG) will release its first quarter 2022 financial results before market open on May 12, 2022. A conference call is scheduled for the same day at 11:00 a.m. ET to discuss the results. Interested parties can access the live call by dialing 888-506-0062 for the U.S. or 973-528-0011 internationally, using access code 199065. The call will also be webcasted on the company’s website, with a replay available for 30 days.
Acacia Research Corporation (ACTG) reported strong financial results for the full year 2021, generating $149.2 million in net income, equating to $1.91 per diluted share. This performance was fueled by $76.0 million in revenue from its Intellectual Property segment and $116.1 million in realized gains primarily from its Life Sciences Portfolio. The company completed the acquisition of Printronix for $33 million, contributing $12.0 million to revenues. In 2022, it anticipates revenues between $13.0 million and $14.0 million for Q1, with a new $40 million stock repurchase program approved.
Acacia Research Corporation (NASDAQ: ACTG) will release its fourth quarter and year-end 2021 financial results on March 31, 2022, before the market opens. A conference call to discuss these results is scheduled for 11:00 a.m. ET. Interested parties can access the call by dialing 888-506-0062 in the U.S. or 973-528-0011 internationally. The call will also be webcast on Acacia's investor relations website. Acacia focuses on acquiring undervalued businesses, leveraging flexible capital and operational expertise across various sectors.
Acacia Research Corporation (NASDAQ: ACTG) has announced significant leadership changes, appointing Martin D. McNulty, Jr. as Chief Operating Officer and Head of M&A, and promoting Wesley L. Golby to Chief Investment Officer. McNulty brings extensive M&A experience, notably from his previous role at Starboard Value Acquisition Corp., where he led a $3.4 billion transaction. Golby has been with Acacia since August 2020, contributing to the acquisition strategy. These appointments are expected to enhance Acacia's operational capabilities and support its growth strategy.
FAQ
What is the current stock price of Acacia Research Corporation (ACTG)?
What is the market cap of Acacia Research Corporation (ACTG)?
What does Acacia Research Corporation specialize in?
What are the core business segments of Acacia?
How much revenue has Acacia generated to date?
What recent acquisitions has Acacia made?
How does Acacia drive value in acquired businesses?
What financial highlights were announced for Q3 2023?
What is the status of Acacia's stock repurchase program?
How much has Acacia returned to its patent partners?
What is the focus of Acacia's Energy Operations segment?